Logo image of ALSOG.PA

SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALSOG - FR0000065864 - Common Stock

25 EUR
+0.2 (+0.81%)
Last: 11/21/2025, 7:00:00 PM
Fundamental Rating

6

ALSOG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 48 industry peers in the Aerospace & Defense industry. ALSOG has an excellent financial health rating, but there are some minor concerns on its profitability. ALSOG scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make ALSOG suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ALSOG was profitable.
ALSOG had a positive operating cash flow in the past year.
ALSOG had positive earnings in 4 of the past 5 years.
In the past 5 years ALSOG always reported a positive cash flow from operatings.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

ALSOG has a Return On Assets of 3.53%. This is comparable to the rest of the industry: ALSOG outperforms 45.83% of its industry peers.
The Return On Equity of ALSOG (11.10%) is comparable to the rest of the industry.
The Return On Invested Capital of ALSOG (9.75%) is better than 64.58% of its industry peers.
ALSOG had an Average Return On Invested Capital over the past 3 years of 6.22%. This is below the industry average of 9.32%.
The 3 year average ROIC (6.22%) for ALSOG is below the current ROIC(9.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.53%
ROE 11.1%
ROIC 9.75%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With a Profit Margin value of 3.17%, ALSOG is not doing good in the industry: 64.58% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of ALSOG has grown nicely.
With a Operating Margin value of 5.80%, ALSOG is not doing good in the industry: 70.83% of the companies in the same industry are doing better.
ALSOG's Operating Margin has improved in the last couple of years.
ALSOG has a better Gross Margin (59.16%) than 85.42% of its industry peers.
In the last couple of years the Gross Margin of ALSOG has remained more or less at the same level.
Industry RankSector Rank
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALSOG is creating some value.
The number of shares outstanding for ALSOG remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ALSOG has an improved debt to assets ratio.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALSOG has an Altman-Z score of 2.49. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
ALSOG has a Altman-Z score of 2.49. This is comparable to the rest of the industry: ALSOG outperforms 50.00% of its industry peers.
ALSOG has a debt to FCF ratio of 1.39. This is a very positive value and a sign of high solvency as it would only need 1.39 years to pay back of all of its debts.
The Debt to FCF ratio of ALSOG (1.39) is better than 87.50% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that ALSOG is not too dependend on debt financing.
ALSOG has a better Debt to Equity ratio (0.44) than 60.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Altman-Z 2.49
ROIC/WACC1.31
WACC7.45%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALSOG has a Current Ratio of 1.66. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
ALSOG has a better Current ratio (1.66) than 79.17% of its industry peers.
A Quick Ratio of 1.41 indicates that ALSOG should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.41, ALSOG belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.41
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.16% over the past year.
The Earnings Per Share has been growing by 18.82% on average over the past years. This is quite good.
ALSOG shows a small growth in Revenue. In the last year, the Revenue has grown by 2.53%.
Measured over the past years, ALSOG shows a quite strong growth in Revenue. The Revenue has been growing by 9.06% on average per year.
EPS 1Y (TTM)76.16%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%

3.2 Future

ALSOG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.42% yearly.
ALSOG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.01% yearly.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.15 indicates a correct valuation of ALSOG.
Compared to the rest of the industry, the Price/Earnings ratio of ALSOG indicates a rather cheap valuation: ALSOG is cheaper than 97.92% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALSOG to the average of the S&P500 Index (25.47), we can say ALSOG is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 9.63, the valuation of ALSOG can be described as reasonable.
Based on the Price/Forward Earnings ratio, ALSOG is valued cheaply inside the industry as 97.92% of the companies are valued more expensively.
ALSOG is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.15
Fwd PE 9.63
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

95.83% of the companies in the same industry are more expensive than ALSOG, based on the Enterprise Value to EBITDA ratio.
100.00% of the companies in the same industry are more expensive than ALSOG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.99
EV/EBITDA 7.21
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ALSOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALSOG has a very decent profitability rating, which may justify a higher PE ratio.
ALSOG's earnings are expected to grow with 18.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3Y18.42%

5

5. Dividend

5.1 Amount

ALSOG has a Yearly Dividend Yield of 3.87%. Purely for dividend investing, there may be better candidates out there.
ALSOG's Dividend Yield is rather good when compared to the industry average which is at 1.19. ALSOG pays more dividend than 100.00% of the companies in the same industry.
ALSOG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.87%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

58.45% of the earnings are spent on dividend by ALSOG. This is a bit on the high side, but may be sustainable.
DP58.45%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (11/21/2025, 7:00:00 PM)

25

+0.2 (+0.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-29 2025-10-29
Earnings (Next)01-27 2026-01-27
Inst Owners4.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap80.00M
Revenue(TTM)158.49M
Net Income(TTM)5.03M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.87%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP58.45%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.15
Fwd PE 9.63
P/S 0.5
P/FCF 3.99
P/OCF 3.75
P/B 1.77
P/tB 3.26
EV/EBITDA 7.21
EPS(TTM)1.65
EY6.6%
EPS(NY)2.6
Fwd EY10.38%
FCF(TTM)6.27
FCFY25.09%
OCF(TTM)6.68
OCFY26.7%
SpS49.53
BVpS14.16
TBVpS7.68
PEG (NY)0.57
PEG (5Y)N/A
Graham Number22.93
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 11.1%
ROCE 11.29%
ROIC 9.75%
ROICexc 12.06%
ROICexgc 17.44%
OM 5.8%
PM (TTM) 3.17%
GM 59.16%
FCFM 12.66%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)10.8%
ROICexgc(5y)N/A
ROCE(3y)7.22%
ROCE(5y)N/A
ROICexgc growth 3Y2.87%
ROICexgc growth 5YN/A
ROICexc growth 3Y7.7%
ROICexc growth 5YN/A
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.39
Debt/EBITDA 1.61
Cap/Depr 38.54%
Cap/Sales 0.82%
Interest Coverage 9.7
Cash Conversion 170.17%
Profit Quality 398.97%
Current Ratio 1.66
Quick Ratio 1.41
Altman-Z 2.49
F-Score8
WACC7.45%
ROIC/WACC1.31
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.16%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%68.09%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)2.53%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%1.85%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
EBIT growth 1Y48.74%
EBIT growth 3Y20.81%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3Y38.24%
EBIT Next 5YN/A
FCF growth 1Y978.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y779.78%
OCF growth 3Y101.39%
OCF growth 5YN/A

SOGECLAIR / ALSOG.PA FAQ

What is the fundamental rating for ALSOG stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALSOG.PA.


What is the valuation status for ALSOG stock?

ChartMill assigns a valuation rating of 8 / 10 to SOGECLAIR (ALSOG.PA). This can be considered as Undervalued.


What is the profitability of ALSOG stock?

SOGECLAIR (ALSOG.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for ALSOG stock?

The financial health rating of SOGECLAIR (ALSOG.PA) is 6 / 10.


What is the earnings growth outlook for SOGECLAIR?

The Earnings per Share (EPS) of SOGECLAIR (ALSOG.PA) is expected to grow by 26.7% in the next year.